Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   


Home > > Science Meeting Summaries & Special Reports > Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS > Index


Header - Pain, Opioid, and Addiction: An Urgent Problem for Doctors and Patients

Disclaimer: The views expressed by presenters in the Science Meeting Summaries and Special Reports do not necessarily reflect the views of NIDA.

Please note: All presentations are available in both PowerPoint and PDF file formats. Large files may take longer to download.

INTRODUCTION / OVERVIEW / PLENARY

HIV/AIDS in 2007: A Brief Overview
Anthony S. Fauci, M.D.

NIH AIDS Research Priorities
Jack Whitescarver, Ph.D.

Drug Abuse Treatment in HIV Prevention and Care: Past Successes and Future Challenges
David S. Metzger, Ph.D.

The Role of Drug Abuse in the Evolving HIV Epidemic
Steffanie A. Strathdee, Ph.D.

DRUG ABUSE, HIV, AND THE BRAIN

Neuroeconomics: New Approaches to Risky Decisionmaking
Gregory S. Berns, M.D., Ph.D.

Neuroimaging To Predict High-Risk Behaviors in Methamphetamine Users
Martin P. Paulus, M.D.

NeuroAIDS in Drug Users
Justin McArthur, M.D.

Methamphetamine and HIV: CNS Effects
Igor Grant, M.D.

DRUG ABUSE, HIV, AND SEXUAL RISK BEHAVIORS

Behavioral Risk and HIV-1 Molecular Diversity: Making the Connections
Chris C. Beyrer, M.D., M.P.H.

Alcohol and HIV Risk Behaviors
Michael D. Stein, M.D.

Methamphetamine Use and HIV
Grant N. Colfax, M.D.

DRUG TREATMENT AS HIV PREVENTION

Does Treatment for Methamphetamine Dependence Reduce HIV Risk Behavior in non-MSM Treatment Samples?
Richard A. Rawson, Ph.D.

Combined Pharmacological and Behavioral Therapy and HIV Risk Reduction
Kenzie L. Preston, Ph.D.

Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective
Marek C. Chawarski, Ph.D.

DRUG ABUSE AND HIV/AIDS: WOMEN AND YOUTH

Do Sex and Drug Behavior Patterns Account for HIV/STD Racial Disparities?
Denise D. Hallfors, Ph.D.

Influences of Marijuana Use on HIV/STI Acquisition and Care
Jonathan M. Ellen, M.D.

How Does Trauma Contribute to Substance Abuse and HIV Infection Among Ethnic Women?
Gail E. Wyatt, Ph.D.

Womenís Interagency HIV Study: Association of Substance Use With HIV Clinical Outcomes, Metabolic Conditions, and Psychiatric Comorbidity
Kathryn Anastos, M.D.

HIV PREVENTION IN CRIMINAL JUSTICE POPULATIONS

HIV/AIDS and the Criminal Justice System
Theodore M. Hammett, Ph.D.

A Multisite HIV Prevention Protocol for Drug-Involved Offenders Returning to the Community
James A. Inciardi, Ph.D.

HIV Testing Strategies and Linkage To Care for Criminal Justice Populations
Timothy P. Flanigan, M.D.

TESTING AND COUNSELING POLICY

HIV Screening and Care: Effect on Clinical Outcomes, Transmission, and Cost
David Paltiel, Ph.D., M.B.A.

CDCís Recommendations for HIV Screening in Health Care Settings
Bernard M. Branson, M.D.

Delay From Testing HIV-Positive Until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions
Barbara J. Turner, M.D., M.S.Ed.

EXPANDING HIV TESTING AND COUNSELING INTO COMMUNITY SETTINGS

Ethical Challenges for Research-Related HIV Testing and Counseling: Community Perspectives
Celia Fisher, Ph.D.

HIV Testing and Counseling in Drug Abuse Treatment
James L. Sorensen, Ph.D.

Voluntary Counseling and Testing: An International, Randomized Community Trial
David D. Celentano, Sc.D., M.H.S.

science meeting summaries and special reports



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal